Bayer AG (FRA:BAYN) received a €129.00 ($151.76) target price from analysts at Sanford C. Bernstein in a research note issued to investors on Friday. The firm currently has a “buy” rating on the healthcare company’s stock.

A number of other analysts also recently issued reports on BAYN. UBS AG set a €125.00 ($147.06) price objective on shares of Bayer AG and gave the company a “buy” rating in a report on Tuesday, June 27th. Commerzbank Ag set a €124.00 ($145.88) price objective on shares of Bayer AG and gave the company a “buy” rating in a report on Friday. Citigroup Inc. set a €130.00 ($152.94) price objective on shares of Bayer AG and gave the company a “buy” rating in a report on Thursday, October 5th. equinet AG set a €118.00 ($138.82) price objective on shares of Bayer AG and gave the company a “buy” rating in a report on Friday. Finally, J P Morgan Chase & Co set a €125.00 ($147.06) target price on shares of Bayer AG and gave the stock a “buy” rating in a report on Monday, August 7th. Eight investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of €121.68 ($143.16).

WARNING: This report was reported by American Banking News and is the property of of American Banking News. If you are accessing this report on another publication, it was illegally copied and republished in violation of international trademark & copyright laws. The original version of this report can be viewed at https://www.americanbankingnews.com/2017/10/13/bayer-ag-bayn-given-a-129-00-price-target-at-sanford-c-bernstein.html.

About Bayer AG

.

Analyst Recommendations for Bayer AG (FRA:BAYN)

Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with MarketBeat.com's FREE daily email newsletter.